These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 4233648

  • 1. [The cytostatic action mechanism of Natulan].
    Weitzel G, Schneider F, Kummer D, Ochs H.
    Z Krebsforsch; 1968; 70(4):354-65. PubMed ID: 4233648
    [No Abstract] [Full Text] [Related]

  • 2. [Further studies on the cytostatic effect of thymine thioethers of 2-imidazolethione].
    Guglielmi H, Athen B, Kummer D, Seeber S, Warnecke P, Straub OC.
    Hoppe Seylers Z Physiol Chem; 1969 Nov; 350(11):1394-400. PubMed ID: 5362612
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on the mechanism of cytostatic action of methylhydrazine, II].
    Weitzel G, Schneider F, Fretzdorff AM, Durst J, Hirschmann WD.
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):433-42. PubMed ID: 5587962
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G.
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract] [Full Text] [Related]

  • 7. [RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
    BEGEMANN H, BLUM KU, FELLMER KE, FOELSCH E, GERHARTZ H, GRUNZE H, HAUSMANN K, HENNES R, JUENGLING W, KLEIBEL F, KOERTGE P, MARING H, MARTIN H, OBRECHT P, OSTEN W, PABST HW, POLIWODA H, SCHUBERT JC, SEIDL S, SPECHTER HJ, STRICKSTROCK KH, WITTE S, DREWS J.
    Med Klin; 1965 Jun 11; 60():960-4. PubMed ID: 14304965
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experiences with the cytostatic drug natulan].
    Kohout J.
    Med Klin; 1969 May 09; 64(19):898-901. PubMed ID: 5819002
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Results of treatment of malignant granuloma with Natulan Roche].
    Lawkowicz W, Krzemińska-Lawkowiczowa, Kolakowska-Polubiec K, Polubiec A.
    Wiad Lek; 1968 Aug 15; 21(16):1417-9. PubMed ID: 5699696
    [No Abstract] [Full Text] [Related]

  • 13. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K, Haas H, Meyerhold A.
    Wien Klin Wochenschr; 1965 Sep 10; 77(36):589-602. PubMed ID: 5323247
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of Hodgkin's disease with Natulan].
    Anglesio E.
    Minerva Med; 1965 Dec 15; 56(100):4402-6. PubMed ID: 5324896
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F, Lasheras Garde J, Triginer Boixeda J.
    Sangre (Barc); 1966 Dec 15; 11(3):265-70. PubMed ID: 6012465
    [No Abstract] [Full Text] [Related]

  • 17. [Varying modification of nucleoside phosphorylation of lymphatic cells by cytostatics effective in Hodgkin's disease].
    Warnecke P, Seeber S.
    Klin Wochenschr; 1969 Oct 15; 47(20):1118-9. PubMed ID: 5381999
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.